COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico

SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment

(2021) Chien-Ting Wu et al.   Cell Metabolism

The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection

(2021) Anthony J. Carlos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study

(2021) Manouchehr Avatef Fazeli et al.   MYCOSES

ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries

(2021) Shivaprakash M. Rudramurthy et al.   MYCOSES

COVID-19, corticosteroids and public health: a reappraisal

(2021) M. Fernandes et al.   PUBLIC HEALTH

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic

(2021) Kundakarla Bhanuprasad et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Integration of fungal diseases into health systems in Latin America

(2020) Juan Luis Rodriguez Tudela et al.   LANCET INFECTIOUS DISEASES

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes

(2020) Janine Alessi et al.   Diabetology & Metabolic Syndrome

High GRP78 levels in Covid-19 infection: A case-control study

(2020) Ramazan Sabirli et al.   LIFE SCIENCES

Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases

(2017) Dora E Corzo-León et al.   MEDICAL MYCOLOGY

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice

(2010) Mingfu Liu et al.   JOURNAL OF CLINICAL INVESTIGATION